Search Within

MSK Grad Students

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (397)
  2. Meeting Abstract (268)
  3. Editorial (8)
  4. Miscellaneous (8)
  5. Research Letter (8)
  6. Review (7)
  7. Conference Paper (2)
  8. Correspondence (1)
  9. Guidelines (1)
Groups
  1. Human Oncology and Pathogenesis Program (700)
  2. GSK Faculty (698)
  3. Department of Medicine (588)
  4. Sloan Kettering Institute Postdocs (478)
  5. Solid Tumor Oncology Division (372)
  6. Epidemiology and Biostatistics (358)

More Groups

People
  1. Nikolaus Schultz (148)
  2. Michael Berger (108)
  3. Vinod Balachandran (99)
  4. David Solit (96)
  5. William Jarnagin (93)
  6. Marcel Van Den Brink (91)

More People

Years
  1. 2025 (26)
  2. 2024 (86)
  3. 2023 (74)
  4. 2022 (100)
  5. 2021 (73)
  6. 2020 (104)

More Years

Publications
  1. Journal of Clinical Oncology (74)
  2. Cancer Research (71)
  3. Blood (66)
  4. Clinical Cancer Research (44)
  5. Annals of Surgical Oncology (39)
  6. Biology of Blood and Marrow Transplantation (30)

More Publications

Publishers
  1. American Association for Cancer Research (150)
  2. Nature Publishing Group (104)
  3. American Society of Clinical Oncology (85)
  4. American Society of Hematology (68)
  5. Cell Press (55)
  6. Elsevier Inc. (45)

More Publishers

Results (700)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
    Journal Article

    Mu, P.; Zhang, Z.; Benelli, M.; Karthaus, W. R.; Hoover, E.; Chen, C. C.; Wongvipat, J.; Ku, S. Y.; Gao, D.; Cao, Z.; more...
    Science (2017)

    Fulltext@MSK | Save
  • Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer
    Journal Article

    Yang, Z.; Peng, Y. C.; Gopalan, A.; Gao, D.; Chen, Y.; Joyner, A. L.
    Disease Models & Mechanisms (2017)

    Fulltext@MSK | Save
  • RNA binding protein SYNCRIP regulates the leukemia stem cell program
    Meeting Abstract

    Vu, L. P.; Prieto, C.; Amin, E.; Minuesa, G.; Chhangawala, S.; Vidal, M. J.; Krivtsov, A. V.; Chou, T.; Barlowe, T.; Taggart, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • JAK2V617F promotes atherosclerosis
    Meeting Abstract

    Wang, W.; Wang, Y.; Woods, B.; Abramowicz, S.; Welch, C.; Levine, R. L.; Tall, A.; Wang, N.
    Blood (2016)

    Fulltext@MSK | Save
  • Activation of JAK/STAT signaling in megakaryocytes is necessary and sufficient for myeloproliferation in vivo
    Meeting Abstract

    Wen, Q. J.; Woods, B.; Yang, Q.; Sophia, C.; Lillu, G.; Rapaport, F.; Levine, R. L.; Crispino, J.
    Blood (2016)

    Fulltext@MSK | Save
  • Selection of unrelated allogeneic hematopoietic cell donors based on KIR3DL1 allotypes is feasible and results in improved disease-free survival in transplant recipients with MDS and AML
    Meeting Abstract

    Shaffer, B. C.; Heller, G.; Le Luduec, J. B.; Vahradian, J.; Perales, M.; Giralt, S. A.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity
    Meeting Abstract

    Kunimoto, H.; Meydan, C.; Nazir, A.; Shank, K.; Maher, R.; Rapaport, F.; Pronier, E.; Melnick, A.; Levine, R. L.; Shih, A. H.
    Blood (2016)

    Fulltext@MSK | Save
  • JAK1 as a convergent regulator of hematopoietic stem cell function and stress hematopoiesis
    Meeting Abstract

    Kleppe, M.; Spitzer, M. H.; Li, S.; Dong, L.; Papalexi, E.; Hill, C.; De Groote, S.; Keller, M.; Koppikar, P.; Rapaport, F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of genomic alterations on outcomes in myelofibrosis patients undergoing allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Rampal, R. K.; Tamari, R.; Zhang, N.; McNamara, C. J.; Rapaport, F.; Litvin, R.; Maloy, M. A.; Castro-Malaspina, H.; Giralt, S.; Weinberg, R. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save